KENDALL ROGERS: Open Payments
NPI 1760118160 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 42 payments from 14 companies in 2025. Trend: 2023 $1,429 · 2024 $1,746 · 2025 $1,089
Food & beverage: $910Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $211 |
| Regeneron Healthcare Solutions, Inc. | 3 | $151 |
| ABBVIE INC. | 9 | $142 |
| GENZYME CORPORATION | 3 | $105 |
| PFIZER INC. | 1 | $95 |
| Lilly USA, LLC | 3 | $80 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $56 |
| UCB, Inc. | 2 | $49 |
| Amgen Inc. | 2 | $41 |
Products named: DUPIXENT, TREMFYA, LITFULO, TALTZ, RINVOQ, SKYRIZI, Winlevi, Bimzelx.
Industry payments across CA — which companies pay providers there.
